Top 5 Medical Device VC (Venture Capital) Funds in El Salvador in July 2025

Last updated: Jul 2025 A list of 5 VC (Venture Capital) funds that invest in Medical device startups based in El salvador. We rank investors based on the number of investments they made in Medical device companies from El salvador. We update this investor list every month.

Top 5 Medical Device VC (Venture Capital) Funds in El Salvador in July 2025

Investor	Medical Device El Salvador investments
Wealthing VC Club	1
cultivate(MD)	1
Sand Hill Angels	1
Mountain State Capital	1
Alumni Ventures	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

A boutique investment group for accredited investors focused on co-investing in post-seed deals led by VCs.

Investment focus

Software, Health Care, Medical Device
Series B, Seed, Convertible Note
United States, El Salvador

Portfolio highlights

Avenda Health — Transforming prostate cancer treatment from a major hospitalization into a SIMPLE office visit while preserving quality of life.
De Oro Devices — De Oro Devices is a device that re-establishing the connection between the brain and the body. Attach a NexStride to cane, walker, and walking poles that help to reduce the duration and frequency of freezing episodes.
Wavely Diagnostics — Wavely Diagnostics is pioneering the future of remote digital diagnostics and enabling telehealth growth by leveraging smartphone technology to address pediatric care.

cultivate(MD) is a unique, medical venture capital fund.

Investment focus

Medical Device, Health Care, Biotechnology
Seed, Series A, Funding Round
United States, El Salvador

Portfolio highlights

NANOCHON — 0 false 18 pt 18 pt 0 0 false false false /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-parent:"
SentiAR — SentiAR is digital health, software device company adding a new dimension to clinical practice in interventional procedures. Spun out of Washington University, we are developing the first 3D visualization platform using real-time holography of the patient's anatomy and catheter location, "floating" over the patients, with a goal toprovide the clinician and patient a faster, safer delivery of care.SentiAR’s mission is to transform the experience for both patient and clinician in interventional procedures with a 3D augmented reality platform featuring real-time holographic visualization of the patient’s actual anatomy, “floating” over the patient.The visualization is fully controllable “hands-free” by the clinician, providing an ergonomic breakthrough for the treatment and analysis of cardiac arrhythmias within an interventional catheter lab environment. SentiAR is developing the platform for eventual FDA submission.
Virtual Incision — Virtual Incision is on a mission to miniaturize robotic surgery, so more patients, surgeons, and healthcare facilities can have access to its benefits every day.

For over two decades, Sand Hill Angels has worked openly and collaboratively with venture capital funds, other angel organizations, and the Bay Area ecosystem that fosters the growth of technology startups.

Investment focus

Health Care, Software, Biotechnology
Seed, Series B, Series A
United States, Canada, Japan

Portfolio highlights

Earthshot Labs — We are an open-source community, public benefit technology company, and regenerative asset manager using data science for planetary-scale climate mitigation.
RevelAi Health — RevelAi Health delivers AI-agent powered care coordination and patient engagement tools to optimize healthcare delivery. By leveraging large language models and machine learning, RevelAi identifies care gaps, automates outreach, and improves outcomes, with a strong emphasis on underserved populations. The platform integrates seamlessly intoclinical systems, aligning with value-based care models and addressing both clinical needs and Social Determinants of Health (SDOH), with a specialization in orthopedic care.
VIAN Therapeutics — VIAN Therapeutics is an early-stage biotechnology company focused on transforming retinal disease treatment. With a first-in-class, non-invasive eyedrop as its lead product, VIAN aims to replace invasive injections for conditions like age-related macular degeneration (AMD) and diabetic macular edema (DME). Backed by strong preclinical data andongoing clinical testing, VIAN is positioned to address significant unmet medical needs and disrupt the $15 billion retinal disease market.

Mountain State Capital is a venture capital firm that seeks to invest in early-stage companies spanning a variety of technology and industry sectors. The firm also provides early-stage risk capital to high-growth companies in the Appalachian region.

Investment focus

Software, Medical Device, Health Care
Seed, Convertible Note, Series A
United States, El Salvador

Portfolio highlights

Aspinity — Aspinity offers neuromorphic all-analog integrated circuit technology that can replicate the functionality of digital signal processors. It reduces the system power requirements for always-on sensing applications.Their vision is that battery life does not have to stand in the way.It was founded in 2015 and headquartered in Pittsburgh,Pennsylvania.
NANOCHON — 0 false 18 pt 18 pt 0 0 false false false /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-parent:"
Avisi Technologies — Avisi Technologies is developing a nanotechnology-enabled defense against blindness from glaucoma.

Alumni Ventures Group provides high-quality, diversified venture portfolios to individual investors who previously haven't had access to VC.It helps accredited alums from top entrepreneurial schools invest together in the ventures of fellow alums. The firm backs companies with an alumni connection and an institutional lead investor withexpertise in the space. AVG also offers focused funds that allow any accredited investor access to a venture portfolio, diversified by type, sector, stage, and geography.Beth Obermiller, Michael Madden, and Mike Collins co-founded the firm in Manchester, New Hampshire in 2013.